Commons2nd reading

Gamma-Butyrolactone (Prohibition) Bill

To provide for the classification of gamma-butyrolactone as a Class C drug under the Misuse of Drugs Act 1971; and for connected purposes

Originating House

House of Commons

Parliament last updated

7 November 2008

In Plain English

AI-generated

May contain errors — check source documents for definitive information.

This bill would treat gamma-butyrolactone (GBL) as a Class C drug under the Misuse of Drugs Act 1971. In practical terms, GBL would become a controlled substance, with offences created for possession, production, or supply, and with the usual penalties and enforcement powers that apply to Class C drugs. It also provides for related provisions to enable the reclassification and its enforcement.

Key Points

Reclassifies gamma-butyrolactone as a Class C drug under the Misuse of Drugs Act 1971.
Creates or clarifies offences around possession, production, supply, and importation of GBL.
Includes connected provisions to implement the reclassification and its enforcement.

Who is affected?

People who use gamma-butyrolactone (GBL)People involved in manufacturing, importing, or supplying GBLBusinesses that handle GBL as a chemicalLaw enforcement and the courts

Generated 21 February 2026

Bill Stages

1st readingCommons

28 Oct 2008

2nd readingCommons

Committee stageCommons

Report stageCommons

3rd readingCommons

1st readingLords

2nd readingLords

Committee stageLords

Report stageLords

3rd readingLords

Royal Assent

Parliamentary Votes (0)

No recorded votes for this bill yet.